The Michigan Sickle Cell Data Collection Program has been tracking information from the estimated 4,000 Michigan residents ...

CRISPR Therapeutics, whose CEO is Samarth Kulkarni, and Vertex Pharmaceuticals earned the first U.S. Food and Drug ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

David Liu couldn’t sleep after the U.S. Food and Drug Administration cleared the first clinical trial based on his research.

Beam to Host Investor Webcast on Friday, June 13, 2025, at 4:00 p.m. ET ...

Kennedy Jr. said 35 states have agreed to participate in a federal pilot program aimed at helping Medicaid patients access costly gene therapies for sickle cell disease. The states represent about ...

The findings were part of a research project commissioned by London Ambulance Service (LAS) NHS Trust and carried out by the Sickle Cell Society. LAS said it had developed an action plan to ...

A Bahrain study shows CT scans to check for blood clots in lung blood vessels increased significantly in people with sickle ...

The quality of life of patients with sickle cell anemia is severely compromised similar to or even worse than patients with other chronic diseases such as arthritis. Patients who responded to ...

Bhopal: Governor Mangubhai Patel inaugurated the genetic analysis laboratory and DNA sequencer machine at BMHRC's sickle cell anaemia competence centre. He also launched a seminar titled "Genetic ...

(KOLN) - Groundbreaking advancements in Sickle Cell treatment are changing and saving ... hoping to bring a different therapy that uses a DNA-editing bacteria technology called CRISPR.